SavedAdd your journal

Journals / International Journal of Medical Biochemistry / 2022 / Cilt: 5 - Sayı: 1

Estimated glomerular filtration rate in identifying illness severity in newly admitted patients with COVID-19: A single-center study

Cuma Bülent GÜL
Nizamettin KOCA
Yasemin ÜSTÜNDAĞ
Kağan HUYSAL
Rahime Feyza KOLOĞLU
Cuneyt ERİŞ
Ali ASAN
Fatma Tuba ENGİNDENİZ
Canan Erdem GENİM
Emine SEVGİCAN
Pages
44–48
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The median age of group 2 was higher thangroup 1: 69 interquartile range (IQR 23) years versus 39 (IQR 23) years (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Early prediction of risk factors for serious illness and death in patients with coronavirus disease 2019 (COVID-19) appears to be a priority.
📊
Key Findings & Data:This study aimed to examine whether a single estimated glomerular filtration rate (eGFR) at triage predicts the need for intensive care unit (ICU) admission of patients with COVID-19.
💡
Conclusion & Impact:The median age of group 2 was higher thangroup 1: 69 interquartile range (IQR 23) years versus 39 (IQR 23) years (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Early prediction of risk factors for serious illness and death in patients with coronavirus disease 2019 (COVID-19) appears to be a priority. This study aimed to examine whether a single estimated glomerular filtration rate (eGFR) at triage predicts the need for intensive care unit (ICU) admission of patients with COVID-19. Methods: This retrospective study included data from patients with COVID-19 at the Bursa Yuksek Ihtisas Training and Research Hospital until October 2020. Patients were assigned to two groups according to their eGFR level at admission: group 1 (eGFR >60 mL/min/1.73 m2) and group 2 (eGFR=30-60 mL/min/1.73 m2). Results: The results of 1447 consecutive patients diagnosed with COVID-19 were analyzed at hospital admissions. Othese, 1001 patients who met the study criteria were included in the study. The median age of group 2 was higher thangroup 1: 69 interquartile range (IQR 23) years versus 39 (IQR 23) years (p

🔖

Cite This Article

GÜL, C. B., KOCA, N., ÜSTÜNDAĞ, Y., HUYSAL, K., KOLOĞLU, R. F., ERİŞ, C., ASAN, A., ENGİNDENİZ, F. T., GENİM, C. E., SEVGİCAN, E. (2022). Estimated glomerular filtration rate in identifying illness severity in newly admitted patients with COVID-19: A single-center study. International Journal of Medical Biochemistry, Cilt: 5 - Sayı: 1, 44–48. https://ajindex.com/articles/541395

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jain U. Effect of COVID-19 on the Organs. Cureus 2020;12(8):e9540
  2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–62
  3. Asan A, Üstundag Y, Koca N, Şimsek A, Sayan HE, Parildar H, et al. Do initial hematologic indices predict the severity of COVID-19 patients? Turk J Med Sci 2021;51(1):39–44
  4. Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health 2020;13(12):1833–9
  5. Zheng X, Chen J, Deng L, Fang Z, Chen G, Ye D, et al. Risk factors for the COVID-19 severity and its correlation with viral shedding: A retrospective cohort study. J Med Virol 2021;93(2):952–61
  6. Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, et al. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res 2020;158:104931
  7. Tian T, Zhang J, Hu L, Jiang Y, Duan C, Li Z, et al. Risk factors associated with mortality of COVID-19 in 3125 counties of the United States. Infect Dis Poverty 2021;10(1):3
  8. Al-Salameh A, Lanoix JP, Bennis Y, Andrejak C, Brochot E, Deschasse G, et al. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes. Diabetes Metab Res Rev 2021;37(3):e3388
  9. Halacli B, Kaya A, Topeli A. Critically-ill COVID-19 patient. Turk J Med Sci 2020;50:585–91
  10. James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, et al; Alberta Kidney Disease Network. CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 2009;54(1):24–32
  11. Suk Cw, Hsu Sc, Chen Cy, Hsieh HL, Kuo HT, Hsu YP, et al. Point of care eGFR and the prediction of outcomes in pneumonia. Sci Rep 2019;11;9(1):8478
  12. Altiparmak MR, Seyahi N, Trabulus S, Yalin SF, Bolayirli M, Andican ZG, et al. Applicability of a different estimation equation of glomerular filtration rate in Turkey. Ren Fail 2013;35(8):1116–23
  13. Turkey Ministry of Health. Guides of COVID-19. Available at: https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_ Rehberi.pdf. Accessed Mar 1, 2021
  14. Uribarri A, Núñez-Gil IJ, Aparisi A, Becerra-Muñoz VM, Feltes G, Trabattoni D, et al; HOPE COVID-19 Investigators. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COV